← Back to Clinical Trials
Recruiting NCT04759443

NCT04759443 Detection of Small Fiber Neuropathy Using Skin Properties

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04759443
Status Recruiting
Phase
Sponsor Brigham and Women's Hospital
Condition Small Fiber Neuropathy
Study Type OBSERVATIONAL
Enrollment 400 participants
Start Date 2021-07-01
Primary Completion 2027-02-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Image processing of skin

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 400 participants in total. It began in 2021-07-01 with a primary completion date of 2027-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Small fiber neuropathy affects millions of peoples worldwide. The neuropathy is causing disabling burning pain and dysautonomia such as dizziness with standing, brain fog, fatigue, constipation, too much or too little sweating. The detection of nerve damage is complicated and not widely available; it requires either skin biopsy or specialized equipment and training. This project utilizes the mathematical processing of skin pictures for the purpose to extract the statistical features related to loss of small fibers. This approach can improve the availability of diagnosis of small fiber neuropathy.

Eligibility Criteria

Inclusion Criteria: * Patients with age 18 year or older * Patients that sign the informed consent form to participate in this study * Patients completed the autonomic testing with skin biopsies Exclusion Criteria: * Patients with significant hairs at the legs that will cover the skin * Any dermatological disorder that can affect the skin composition * The use of skin lotion

Contact & Investigator

Central Contact

Peter Novak, MD

✉ pnovak2@bwh.harvard.edu

📞 617-732-7432

Frequently Asked Questions

Who can join the NCT04759443 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Small Fiber Neuropathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04759443 currently recruiting?

Yes, NCT04759443 is actively recruiting participants. Contact the research team at pnovak2@bwh.harvard.edu for enrollment information.

Where is the NCT04759443 trial being conducted?

This trial is being conducted at Boston, United States.

Who is sponsoring the NCT04759443 clinical trial?

NCT04759443 is sponsored by Brigham and Women's Hospital. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology